Chemical formula: C₂₁H₂₇N₅O₄S Molecular mass: 445.535 g/mol PubChem compound: 3478
Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class. The primary mode of action of glipizide is the stimulation of insulin secretion from the beta-cells of pancreatic islet tissue.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A10BB07 | Glipizide | A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| GLIZIPIDE Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| GLUCOTROL XL Extended-release tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| GLUCOTROL Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Glipizide is an active ingredient of these brands:
United States (US)Austria (AT)Brazil (BR)France (FR)Israel (IL)Lithuania (LT)Mexico (MX)Nigeria (NG)Poland (PL)Romania (RO)South Africa (ZA)Spain (ES)Tunisia (TN)Turkey (TR)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
